Residency · Residency · Internal Medicine
Syncope: A Systematic Diagnostic Approach
Definition and Epidemiology
Syncope is a transient loss of consciousness caused by cerebral hypoperfusion, characterized by rapid onset, brief duration, and spontaneous complete recovery. It accounts for 1 to 3 percent of emergency department visits and up to 6 percent of hospital admissions. The lifetime prevalence is approximately 35 to 40 percent, with a recurrence rate of about 30 percent over three years. The prognosis varies dramatically by etiology: cardiac syncope carries 18 to 33 percent one-year mortality, compared to 0 to 12 percent for non-cardiac causes.
Classification
Reflex (Neurally Mediated) Syncope
Vasovagal syncope is the most common type overall, accounting for 21 to 35 percent of cases. It is triggered by prolonged standing, emotional stress, pain, or heat exposure, and typically preceded by a classic prodrome of lightheadedness, warmth, nausea, diaphoresis, and tunnel vision. The underlying mechanism is paradoxical vagal activation via the Bezold-Jarisch reflex, producing bradycardia and/or vasodilation. Situational syncope occurs with specific triggers such as micturition, defecation, cough, swallowing, or post-exercise. Carotid sinus hypersensitivity causes syncope with head turning or tight collars, predominantly in elderly males, and can be cardioinhibitory (pause greater than 3 seconds), vasodepressor (SBP drop greater than 50 mmHg), or mixed.
Orthostatic Hypotension
Orthostatic hypotension is defined as a sustained reduction of SBP by 20 mmHg or more or DBP by 10 mmHg or more within three minutes of standing. Causes include volume depletion, medications (alpha-blockers, diuretics, antihypertensives), and autonomic failure. Neurogenic orthostatic hypotension is associated with Parkinson disease, multiple system atrophy, diabetic autonomic neuropathy, and pure autonomic failure. Initial orthostatic hypotension -- a transient drop within the first 15 seconds of standing -- is often missed by standard measurement techniques.
Cardiac Syncope
Arrhythmic causes include bradyarrhythmias (sinus node dysfunction, AV block including Mobitz II and complete heart block), tachyarrhythmias (VT, SVT with rapid rates, torsades de pointes), channelopathies (long QT syndrome, Brugada syndrome, CPVT), and pacemaker malfunction. Structural causes include aortic stenosis (exertional syncope from fixed cardiac output), hypertrophic cardiomyopathy (dynamic LVOT obstruction), massive pulmonary embolism, cardiac tamponade, atrial myxoma (positional syncope), and acute MI.
Initial Evaluation
History -- The Most Important Diagnostic Tool
The history should capture the circumstances (position, activity, triggers such as exertion or postural change), prodromal symptoms (the presence of a prodrome suggests vasovagal; abrupt onset suggests arrhythmia), witness accounts (duration of unconsciousness, abnormal movements, color changes), and the character of recovery (rapid and complete favors syncope; prolonged confusion suggests a seizure or post-ictal state). Prior episodes, frequency, medications (particularly QT-prolonging drugs, antihypertensives, and diuretics), and family history of sudden cardiac death (channelopathies, HCM, ARVC) must all be assessed.
Physical Examination
Orthostatic vital signs should be measured from supine to standing at one and three minutes. Cardiac auscultation may reveal murmurs of aortic stenosis or HCM. Carotid sinus massage is appropriate in patients over 40 years without carotid bruits. The neurological examination should focus on detecting focal deficits, which would suggest an alternative diagnosis such as stroke or TIA -- these are not syncope.
ECG
An ECG must be obtained in every patient presenting with syncope. High-yield findings include prolonged QT, Brugada pattern, pre-excitation (WPW), AV block, bundle branch block, pathological Q waves, ventricular hypertrophy, and epsilon waves (ARVC). A completely normal ECG in a young patient with classic vasovagal features may be sufficient to make the diagnosis.
Risk Stratification
High-Risk Features (Require Admission/Urgent Workup)
High-risk features include syncope during exertion or while supine, associated chest pain or dyspnea, sudden onset palpitations immediately before syncope, known structural heart disease or reduced ejection fraction, family history of sudden cardiac death at a young age, ECG abnormalities (conduction disease, long QT, Brugada), severe anemia or GI bleeding, new neurological deficits, and significant injury from the event.
Clinical Decision Rules
| Decision Rule | Components | Outcome Predicted | Strengths/Limitations |
|---|---|---|---|
| San Francisco Syncope Rule (CHESS) | CHF history, Hct <30, abnormal ECG, SOB, SBP <90 | Serious 7-day outcomes | ~98% sensitivity, low specificity |
| Canadian Syncope Risk Score | Vasovagal predisposition, heart disease, troponin, QRS axis, QTc >480, ED diagnosis, BP | 30-day serious adverse events | Better validated, more granular risk stratification |
| EGSYS Score | Palpitations, abnormal ECG, effort-related, supine, autonomic prodrome, predisposing factors | Cardiac vs. non-cardiac etiology | Score ≥3 suggests cardiac cause |
The San Francisco Syncope Rule (CHESS) incorporates CHF history, hematocrit below 30, abnormal ECG, shortness of breath, and SBP below 90, achieving sensitivity of approximately 98 percent for serious outcomes but with low specificity. The Canadian Syncope Risk Score is better validated in recent studies for 30-day serious adverse events and incorporates predisposition to vasovagal, heart disease history, elevated troponin, abnormal QRS axis, QTc above 480, ED diagnosis, and blood pressure extremes. The EGSYS score helps differentiate cardiac from non-cardiac syncope.
Low-Risk Features (May Permit Outpatient Workup)
Low-risk features include a classic vasovagal prodrome with an identifiable trigger, young age without cardiac history or family history, normal ECG, normal vital signs, and no significant injury.
Diagnostic Testing
Echocardiography
Echocardiography is indicated when cardiac syncope is suspected or structural heart disease is a concern. It evaluates ejection fraction, valvular disease, hypertrophy, RVSP, and pericardial effusion. It has low yield in patients with a normal ECG and no cardiac history.
Cardiac Monitoring
Telemetry provides inpatient monitoring for high-risk patients. Holter monitors (24-48 hours) have a low diagnostic yield of 1 to 2 percent due to the brief monitoring window. Event recorders (2-4 weeks) are patient-activated and better suited for frequent symptoms. Implantable loop recorders (ILRs) offer up to three years of monitoring and the highest diagnostic yield for unexplained recurrent syncope -- the PICTURE study found that ILR identified a cause in 78 percent of patients. Mobile cardiac outpatient telemetry (MCOT) provides continuous monitoring with auto-detection.
Tilt-Table Testing
Tilt-table testing is indicated for suspected vasovagal syncope when the diagnosis is uncertain. The protocol involves passive tilt at 60 to 70 degrees for 20 to 45 minutes, with or without isoproterenol provocation. A positive response reproduces syncope with hypotension and/or bradycardia. The test has a sensitivity of 61 to 69 percent, specificity of about 93 percent, and a false positive rate of 10 to 15 percent. It is also useful for distinguishing vasovagal syncope from psychogenic pseudosyncope when EEG monitoring is performed during the tilt.
Electrophysiology Study (EPS)
EPS is reserved for patients with structural heart disease and unexplained syncope after non-invasive testing has been negative. It evaluates sinus node function, AV conduction, and inducibility of tachyarrhythmias, but has low yield in structurally normal hearts.
Carotid Sinus Massage
Carotid sinus massage is performed under continuous ECG and blood pressure monitoring. A positive result is defined as asystole exceeding 3 seconds or an SBP drop exceeding 50 mmHg. It is contraindicated in patients with a carotid bruit, recent stroke or TIA, or known carotid stenosis.
Tests of Limited or No Value
Head CT and brain MRI are not useful unless focal neurological findings are present. EEG is warranted only when seizure (not syncope) is suspected. Carotid ultrasound should not be ordered because carotid stenosis does not cause syncope. Routine blood work has low diagnostic yield; glucose, CBC, and BMP should be checked only when clinically indicated.
Management by Etiology
Vasovagal Syncope
The first step is education and reassurance about the benign nature of the condition. Counterpressure maneuvers -- leg crossing, hand grip, or arm tensing at the onset of prodromal symptoms -- can abort episodes (Physical Counterpressure Maneuver Trial). Adequate hydration (2-3 L/day) and salt intake (6-10 g/day) are recommended. Trigger avoidance (prolonged standing, dehydration, overheated environments) and tilt training (repeated supervised tilting) may help, though evidence for the latter is limited. For refractory cases, midodrine (an alpha-1 agonist) has modest evidence of benefit from the POST 2 trial, while fludrocortisone showed no benefit over placebo in that same trial. Beta-blockers, historically used, showed no benefit in the POST 1 trial, though an exception may exist for patients over 42 years. Pacemaker implantation is reserved for cardioinhibitory syncope with documented prolonged asystole (greater than 6 seconds), and the BIOSync CLS trial showed benefit of closed-loop stimulation pacing.
Orthostatic Hypotension
Management begins with medication review and adjustment. Physical counterpressure, compression stockings, and abdominal binders help. Head-of-bed elevation reduces nocturnal supine hypertension and diuresis. Midodrine and droxidopa are pharmacologic options for neurogenic orthostatic hypotension, and fludrocortisone can be used with caution in patients without heart failure or hypertension.
Cardiac Syncope
Arrhythmic syncope is managed with pacemaker implantation for bradycardia, ICD for ventricular tachycardia with structural heart disease, and catheter ablation for SVT or accessory pathways. Structural causes require treatment of the underlying condition, such as valve replacement for aortic stenosis or septal reduction for HCM.
Syncope Mimics -- Important Differential Diagnosis
Seizure is suggested by prolonged loss of consciousness, post-ictal confusion, lateral tongue biting, incontinence, and tonic-clonic activity lasting more than 30 seconds. Psychogenic pseudosyncope is characterized by eyes closed during the event (true syncope occurs with eyes open), prolonged duration, high frequency, and normal hemodynamics on tilt testing. Hypoglycemia is not true syncope because it is metabolic rather than from cerebral hypoperfusion, and it requires glucose for recovery. Vertebrobasilar TIA usually produces other neurological symptoms and does not cause isolated transient loss of consciousness. Subclavian steal syndrome causes syncope with arm exercise and demonstrates blood pressure differential between the arms.
<image> A clinical decision algorithm flowchart for syncope evaluation. Starting with "Transient Loss of Consciousness" at the top, branching to "True Syncope vs. Non-Syncopal TLOC (seizure, psychogenic, metabolic)." The syncope branch divides into three pathways: Reflex/Vasovagal (green), Orthostatic (yellow), and Cardiac (red). Each pathway shows key diagnostic features, initial evaluation steps, and management strategies. Include risk stratification criteria for admission vs. outpatient workup. Use color coding to indicate risk levels. </image>
<image> A comparative diagram illustrating the hemodynamic changes during vasovagal syncope versus cardiac syncope. The left panel shows the Bezold-Jarisch reflex mechanism with a timeline graph depicting heart rate and blood pressure changes during a vasovagal episode (initial rise in HR, then paradoxical bradycardia and hypotension). The right panel shows an ECG rhythm strip demonstrating complete heart block with ventricular escape causing cardiac syncope. Include arterial pressure waveforms for both scenarios. </image>
<image> An infographic showing the differential diagnosis of transient loss of consciousness, organized as a central hub with spokes radiating outward. Categories include: Reflex Syncope (vasovagal, situational, carotid sinus), Orthostatic Hypotension (drug-induced, neurogenic, hypovolemic), Cardiac Syncope (arrhythmic, structural), and Non-Syncopal Mimics (seizure, psychogenic, metabolic). Each category lists 3-4 key distinguishing features. Use medical illustration style with consistent color coding. </image>
Clinical Pearls
History is the single most important diagnostic tool in syncope, yielding a diagnosis in up to 50 percent of cases. A normal ECG in a young patient with a classic vasovagal prodrome is low risk and often requires no further workup. Syncope during exertion is cardiac until proven otherwise and always warrants echocardiography and further evaluation. Carotid ultrasound and head CT are almost never indicated for syncope and represent low-value care. Brief myoclonic jerks lasting less than 15 seconds are common during syncope due to cerebral hypoperfusion and should not be confused with a seizure. If the patient did not actually lose consciousness, it is not syncope -- consider presyncope, vertigo, or anxiety instead. Implantable loop recorders have the highest diagnostic yield for recurrent unexplained syncope and should be considered early rather than after exhaustive negative testing. The reflexive ordering of telemetry and echocardiography on every syncope patient should be avoided in favor of proper risk stratification.
References
- Brignole M, et al. 2018 ESC Guidelines for the Diagnosis and Management of Syncope. European Heart Journal. 2018.
- Shen WK, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope. Circulation. 2017.
- Thiruganasambandamoorthy V, et al. Canadian Syncope Risk Score. CMAJ. 2016.
- Sheldon RS, et al. Prevention of Syncope Trial (POST): a randomized clinical trial of beta-blockers. Circulation. 2006.
- Brignole M, et al. BIOSync CLS Trial: Closed-loop stimulation pacing for vasovagal syncope. NEJM. 2021.
- Krahn AD, et al. PICTURE Study: Implantable loop recorder in unexplained syncope. American Heart Journal. 2004.
- van Dijk JG, et al. Recognizing vasovagal syncope. Cardiology Clinics. 2013.
